Skip to main content
LARGAN logo

LARGAN — Investor Relations & Filings

Ticker · 3008 ISIN · TW0003008009 TW Manufacturing
Filings indexed 2,012 across all filing types
Latest filing 2024-11-05 Director's Dealing
Country TW Taiwan
Listing TW 3008

About LARGAN

www.largan.com.tw

LARGAN Precision Co., Ltd. designs and manufactures high-quality optical lens modules and plastic aspherical lenses. Established in 1987, the company specializes in precision optical technology, providing advanced solutions for applications including smartphones, tablets, notebooks, and automotive systems. As a primary supplier to major global brands, LARGAN Precision is recognized for its expertise in high-precision plastic lens production and large-scale manufacturing. Its product portfolio encompasses lenses for mobile devices, scanners, digital cameras, and multi-function printers. The company maintains a strong focus on research and development to drive innovation in imaging performance, delivering high-resolution optical components that meet the rigorous technical requirements of modern mobile technology and automotive applications.

Recent filings

Filing Released Lang Actions
113年10月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings of insiders, including directors, chairpersons, and other executives, with specific numbers of shares held, changes in holdings, and related notes. The content focuses on personal share transactions and holdings by company insiders. There is no indication of financial results, management discussion, legal proceedings, or other report types. The document is not a report publication announcement or a certification letter but a direct disclosure of insider shareholdings. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is sufficient and the content is consistent with insider shareholding disclosures.
2024-11-05 Chinese
113年10月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings of company insiders, including directors and executives, specifying their current holdings, pledged shares, and related information. It focuses on insider share ownership and changes, which aligns with reporting of personal share transactions or holdings by company directors and executives. There is no indication of financial results, meeting materials, or regulatory announcements unrelated to insider holdings. The document length is 2614 characters, which is relatively short but contains substantive insider shareholding data rather than a mere announcement. Therefore, the document fits best under the category of Director's Dealing (DIRS).
2024-11-05 Chinese
113年10月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company (大立光) regarding the status of fund loans and endorsement guarantees for the current and previous month, including cumulative amounts and limits. It contains no detailed financial statements or analysis, nor does it mention any report publication or meeting. The content is a regulatory disclosure about financial guarantees and loans, which fits best under general regulatory announcements rather than a full financial report or other specific categories.
2024-11-05 Chinese
113年10月營業收入
Regulatory Filings Classification · 95% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 大立光 (Largan Precision) for October of the 113th year of the Republic of China calendar (which corresponds to 2024). It includes comparative figures from the previous year and percentage changes. The document is very short (783 characters) and contains no detailed financial statements, management discussion, or comprehensive analysis. It appears to be a regulatory disclosure of monthly revenue figures rather than a full financial report or earnings release. There is no indication of an earnings announcement or conference call transcript, nor is it a notice of dividend, capital change, or other corporate action. Given the nature and length, this fits best as a Regulatory Filing (RNS) which is a general category for miscellaneous regulatory disclosures that do not fit other specific categories.
2024-11-05 Chinese
公告本公司113年第3季合併財務報告
Interim / Quarterly Report Classification · 95% confidence The document is a financial announcement from company 3008 大立光, dated 113/10/28 (Taiwan calendar year 113 corresponds to 2024). It reports consolidated financial results for the third quarter (Q3) of the year 113 (2024), including cumulative revenue, gross profit, operating profit, pre-tax profit, net profit, earnings per share, total assets, liabilities, and equity as of the period ending 113/09/30. The document is 927 characters long, which is relatively short but contains substantive financial data for a quarterly period. It is not merely an announcement of a report publication but includes actual financial figures and performance metrics. Therefore, it fits the definition of an Interim / Quarterly Report (IR). 9M 2024
2024-10-28 Chinese
公告本公司113年第3季合併財務報告董事會召開日期
Regulatory Filings Classification · 95% confidence The document is a short announcement (537 characters) from a company (3008 大立光) stating the date of the board meeting to be held on 113/10/28 to discuss the 3rd quarter consolidated financial report. It does not contain the financial report itself but only announces the upcoming board meeting and the expected report to be presented. According to the MENU VS MEAL RULE, this is an announcement about a report, not the report itself. Therefore, it should be classified as a Regulatory Filing (RNS) since it is a general regulatory announcement that does not fit other specific categories.
2024-10-18 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.